
ABSTRACT Background Anabolic–androgenic steroids (AAS) are widely misused, but molecular markers serving as physiological readouts as well as biomarkers of misuse remain poorly defined. Circulating small noncoding RNAs (sncRNAs) are plausible endocrine‐responsive messengers and candidate biomarkers. Objective To determine whether exogenous testosterone administration acutely and persistently alters circulating sncRNAs. Materials and Methods Randomized, double‐blinded, placebo‐controlled trial in healthy eugonadal men (n = 19; 20–30 years), receiving intramuscular injections of 250 mg mixed testosterone esters as Sustanon 250 or placebo on Day 0 and 21. Serum was collected at Day 0, 1, and 42, and the isolated RNA was subjected to small RNA sequencing using the RealSeq‐Biofluids library kit. A link between miR‐214‐3p and testosterone concentrations was tested on longitudinal serum samples from 29 peri‐pubertal boys with RT‐qPCR, and its expression in testis tissue was investigated by in situ hybridization. Results Twenty‐four hours after testosterone administration, we identified a distinct signature of 19 Sustanon‐responsive sncRNAs (12 upregulated, 7 downregulated), with piRNAs as the most represented class. One of the Sustanon‐specific sncRNAs, miR‐214‐3p, was found to correlate positively with circulating testosterone in peri‐pubertal boys and showed expression in testicular tissue, including testosterone‐producing Leydig cells. Despite testosterone having returned to baseline concentrations at Day 42, 160 sncRNAs remained altered, indicating sustained effects of testosterone use. Intersecting short‐ and long‐term analyses revealed 43 Sustanon‐specific sncRNAs, including the small nucleolar RNA U3. Discussion Despite the modest sample size, this study highlights that multiple sncRNAs respond to testosterone exposure. Further studies are needed to develop a functional, tissue‐specific understanding of the identified sncRNAs. Conclusions Brief supraphysiological testosterone exposure remodels circulating sncRNAs both acutely and over weeks, implicating androgens in systemic RNA‐based communication. Several responsive sncRNAs, notably miR‐214‐3p and snoRNA U3, show potential as biomarkers of androgen misuse.
ABSTRACT Background Sperm DNA fragmentation index (DFI) reflects nuclear DNA damage, but its association with assisted reproductive technology (ART) outcomes remains controversial. Objectives This meta‐analysis evaluated associations between DFI, semen parameters, and ART pregnancy outcomes. Methods Four databases were searched through September 2025 for studies comparing reproductive outcomes between low‐ and high‐DFI groups. Random‐effects models pooled risk ratios (RRs) or weighted mean differences with 95% confidence intervals (CIs). Subgroup, sensitivity, and publication bias analyses were conducted. Results Eighty‐seven studies were included. Low DFI was associated with higher clinical pregnancy rate (RR = 1.121, 95% CI:1.068–1.178), live birth rate (RR = 1.136, 95% CI:1.063–1.215), and embryo implantation rate (RR = 1.198, 95% CI:1.085–1.323), and lower miscarriage risk (RR = 0.731, 95% CI:0.652–0.820). No significant association emerged for biochemical pregnancy rate. After publication bias adjustment, clinical pregnancy and live birth associations lost significance, while embryo implantation and miscarriage associations remained robust. Semen parameters favored the low‐DFI group. Conclusion DFI may serve as a supplementary indicator to routine semen analysis, providing information on sperm DNA integrity to complement the assessment of semen quality and ART reproductive outcomes; however, the current evidence primarily reflects population‐level associations, and its routine clinical utility remains to be further clarified. Clinical Trial Registry Registration number: CRD420261356371
ABSTRACT Background Viral persistence is considered one of the key mechanisms driving long COVID symptoms. The male genital tract (MGT), particularly the testis, is an immune‐privileged site that may serve as a viral reservoir for SARS‐CoV‐2. However, the presence of SARS‐CoV‐2 in semen and its long‐term infectiousness remains controversial. Objectives We aimed to investigate the long‐term presence and potential replicative activity of SARS‐CoV‐2 in semen, evaluating whether the virus can persist and maintain low‐level culture signals in the MGT well beyond the acute phase of infection. Material and Methods This observational, prospective, cross‐sectional study included 38 men treated at Mater Dei Hospital, Brazil, between October 2020 and October 2021, who had recovered from mild to moderate COVID‐19 and consented to participate. Semen samples were collected from mildly symptomatic participants at approximately 1 month (15– 45 days), 3 months, and 6 months after symptom onset. The moderately symptomatic group provided a single sample approximately 6 months post‐infection. Semen analysis and SARS‐CoV‐2 detection were performed using RT‐qPCR, followed by viral isolation in Vero CCL‐81 cells. Potential viral persistence and replication signals were evaluated through immunofluorescence and transmission electron microscopy (TEM). Results SARS‐CoV‐2 was detected by RT‐qPCR in 21 of 38 patients (55%), with high cycle threshold (Ct 38–39) values observed for more than 6 months post‐infection. Following inoculation into Vero cell cultures, a low‐level in vitro expansion of viral copies was identified in a subset of samples from mild and moderate patients. The potential presence of the virus was further supported by the presence of viral proteins via immunofluorescence and the identification of structures morphologically compatible with coronavirus‐like particles by TEM. Conclusion This study provides evidence of the long‐term persistence of viral RNA and culture‐derived signals suggestive of restricted or low‐level replicative activity in semen. These findings suggest that the MGT may serve as a viral reservoir, highlighting the importance of longitudinal semen analysis for monitoring viral persistence and reservoir dynamics after clinical recovery.
ABSTRACT Background Male infertility is usually assessed using separate parameters, while a simple integrated male‐oriented tool is lacking. Objectives To develop a Male Fertility Index (MFI), assess its association with natural conception after varicocelectomy, and perform preliminary external validation. Materials and Methods This two‐center cohort study included 149 infertile men with clinical varicocele: 99 in the development cohort and 50 in the validation cohort. Preoperative variables were analyzed against natural conception within 12 months. ROC‐derived AUCs for total progressively motile sperm count, total motility, male age, and infertility duration were used to construct the MFI. Results Natural conception occurred in 30/99 couples (30.3%). MFI values were higher in men whose partners conceived (1.44 [0.87–2.15] vs. 0.64 [0.25–1.31], p < 0.001). Conception was more frequent with MFI > 0.8 than with MFI ≤ 0.8 (44.4% vs. 13.3%, p = 0.0017). In validation, corresponding rates were 40.0% and 14.3%; AUC was 0.795 (95% CI 0.650–0.911). Discussion The MFI showed a similar association with natural conception in both cohorts, although validation was limited by sample size and incomplete assessment of female factors. Conclusion The MFI may summarize male reproductive status in infertile men with clinical varicocele. Its weighting and cut‐off require confirmation in larger cohorts, and its usefulness in other infertility settings remains to be established.
ABSTRACT Background Fertile human males produce significantly fewer sperm per gram of testes than most other animals, including primates. Human's low sperm output is associated with a lower pregnancy rate per episode of intercourse and a longer time to pregnancy than in most other species. This, coupled with the concealed nature of ovulation in women, means that human couples frequently require numerous acts of intercourse to achieve a pregnancy. The reason for the low fecundability of humans is unknown. Methods I performed a literature review examining the efficiency of spermatogenesis and time to pregnancy in humans to estimate the period of time and average number of episodes of sexual intercourse required for pregnancy. These estimates were corroborated with mathematical models. Hypotheses are suggested to explain the low fecundity of humans. Results The average, fertile human couple has sexual intercourse 17–35 times over 2–6 months to conceive, with some fertile couples requiring longer periods of time. These numbers and time period are greater than for most other species. Among the theories that could be advanced to explain the relatively low fecundability of humans compared with other species, two will be explored here: (i) a reduction in the risk of pre‐eclampsia with repeated sexual intercourse with a single partner over several months and/or (ii) improved pair‐bonding from repeated intercourse over time leading to improved outcomes for children. Conclusions Reduced sperm production in men may be evolutionarily adaptive. Lower fertility and longer time to conception is associated with a reduced risk of pre‐eclampsia and improved outcomes for offspring. Greater understanding of the mechanism(s) involved in the relatively low sperm output in men might provide clues to explain some types of male infertility. Additional research into the reduced efficiency of sperm output in men is warranted.